Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

Various studies indicate that vaccination, especially with pneumococcal vaccines, protects against symptomatic cases of SARS-CoV-2 infection and death. This paper explores the possibility that pneumococcal vaccines in particular, but perhaps other vaccines as well, contain antigens that might be cro...

Descripción completa

Detalles Bibliográficos
Autor principal: Root-Bernstein, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712751/
https://www.ncbi.nlm.nih.gov/pubmed/32987794
http://dx.doi.org/10.3390/vaccines8040559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712751/
https://www.ncbi.nlm.nih.gov/pubmed/32987794
http://dx.doi.org/10.3390/vaccines8040559

Ejemplares similares